Genworth 兴。 | --- | --- | |-------------------------------|-------| | | | | | | | 2Q Investor | | | Presentation Earnings Summary | | | July 31, 2024 | | 2 Cautionary Note Regarding Forward-Looking Statements This presentation contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as "expects," "intends," "anticipates," "plans," "believes," "seeks," "estimates," "will" or words of si ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32195 GENWORTH FINANCIAL, INC. (Exact name of registrant as specified in its charter) Delaware 80-0873306 (State or other ...

Genworth Financial, Inc. (NYSE:GNW) Q2 2024 Earnings Conference Call August 1, 2024 10:00 AM ET Company Participants Brian Johnson - SVP of Financial Planning and Analysis Thomas McInerney - President and CEO Jerome Upton - CFO Conference Call Participants Operator Good morning, ladies and gentlemen, and welcome to Genworth Financial's Second Quarter 2024 Earnings Conference Call. My name is Cynthia, and I will be your coordinator today. At this time, all participants are in a listen-only mode. We will faci ...

Financial Performance - In Q2 2024, Genworth Financial reported total revenues of $1,769 million, a decrease from $1,864 million in Q1 2024[13]. - Net income available to common stockholders for Q2 2024 was $76 million, compared to $139 million in Q1 2024[13]. - The company experienced a net investment loss of $61 million in Q2 2024, contrasting with a gain of $49 million in Q1 2024[13]. - Total benefits and expenses for Q2 2024 were $1,626 million, slightly down from $1,628 million in Q1 2024[13]. - Income from continuing operations before income taxes was $143 million in Q2 2024, down from $236 million in Q1 2024[13]. - The diluted earnings per share for Q2 2024 was $0.17, compared to $0.31 in Q1 2024[13]. - The company reported benefits and other changes in policy reserves of $1,151 million in Q2 2024, compared to $1,203 million in Q1 2024[13]. - Net income available to common stockholders for Q2 2024 was $76 million, compared to $137 million in Q2 2023, reflecting a decrease of 44.6%[15]. - Adjusted operating income for Q2 2024 was $125 million, up from $85 million in Q1 2024, indicating a 47.1% increase[15]. - The company reported a basic earnings per share of $0.17 for Q2 2024, compared to $0.29 in Q2 2023, a decrease of 41.4%[15]. Assets and Liabilities - Total assets as of June 30, 2024, were $87.543 billion, a decrease from $90.817 billion as of December 31, 2023[16]. - Total liabilities decreased to $78.190 billion as of June 30, 2024, from $82.482 billion at the end of 2023, representing a reduction of 5.2%[19]. - Future policy benefits liabilities were $53.774 billion as of June 30, 2024, down from $57.655 billion at the end of 2023, a decline of 6.5%[19]. - Cash and cash equivalents stood at $1.932 billion as of June 30, 2024, slightly down from $2.215 billion at the end of 2023[16]. - Total investments were $58.359 billion as of June 30, 2024, a decrease from $59.751 billion at the end of 2023[16]. - Total assets as of June 30, 2024, amounted to $87,543 million, an increase from $89,192 million as of March 31, 2024[20][21]. - Total liabilities were reported at $78,190 million as of June 30, 2024, compared to $80,313 million as of March 31, 2024[20][21]. Insurance Segment Performance - New insurance written for the Enact segment was reported at $Z million, indicating the volume of new business generated during the quarter[7]. - The loss ratio for the Enact segment was reported at A%, providing insight into underwriting performance for the period[7]. - The Enact segment reported adjusted operating income of $165 million in Q2 2024, compared to $135 million in Q1 2024, a growth of 22.2%[15]. - The Long-Term Care Insurance segment reported an adjusted operating loss of $29 million in Q2 2024, compared to a profit of $3 million in Q1 2024[15]. Investment Performance - Net investment income for Q2 2024 was $808 million, an increase from $782 million in Q1 2024, totaling $1.590 billion for the first half of 2024[53]. - Gross investment income before expenses and fees reached $833 million in Q2 2024, compared to $805 million in Q1 2024, totaling $1.638 billion for the first half of 2024[53]. - The annualized yield for fixed maturity securities - taxable was 4.7% in Q2 2024, up from 4.5% in Q1 2024[53]. - Total net realized investment losses for Q2 2024 amounted to $(60) million, with a total of $(10) million for the first half of 2024[54]. - The net unrealized gains on equity securities still held were $12 million in Q2 2024, increasing to $44 million for the total period[54]. - The company reported net investment gains (losses), gross of $(61) million in Q2 2024, with a total of $(12) million for the first half of 2024[54]. Shareholder Equity - Total stockholders' equity for Genworth Financial, Inc. increased to $8,459 million as of June 30, 2024, compared to $8,006 million on March 31, 2024, reflecting a growth of 5.6%[9]. - Book value per share rose to $19.49 as of June 30, 2024, up from $18.21 as of March 31, 2024, representing an increase of 7.0%[9]. - The number of common shares outstanding decreased to 434.0 million as of June 30, 2024, down from 439.6 million as of March 31, 2024[9]. - The company’s total equity stood at $9,353 million as of June 30, 2024, down from $8,879 million as of March 31, 2024[20][21]. Operational Metrics - Management continues to focus on enhancing operational performance through strategic measures, including monitoring key performance indicators such as insurance in-force and risk in-force[7]. - The weighted-average common shares outstanding for diluted calculations were 440.7 million in Q2 2024, down from 450.3 million in Q1 2024[13]. - The expense ratio increased by five percentage points for the three months ended June 30, 2024[27]. - The primary delinquency rate improved to 1.96% in Q2 2024 from 2.01% in Q1 2024, indicating a decrease of 0.05 percentage points[31]. - The total number of primary delinquencies at the end of Q2 2024 was 19,051, a decrease from 20,432 in Q4 2023[31].

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32195 GENWORTH FINANCIAL, INC. (Exact name of registrant as specified in its charter) Delaware 80-0873306 (State or other ...

Genworth Financial, Inc. (NYSE:GNW) Q1 2024 Earnings Conference Call May 2, 2024 9:00 AM ET Company Participants Sarah Crews - Head, IR Thomas McInerney - President & CEO Jerome Upton - EVP & CFO Conference Call Participants Operator Good morning, ladies and gentlemen, and welcome to Genworth Financial's First Quarter 2024 Earnings Conference Call. My name is Cynthia, and I will be your coordinator today. [Operator Instructions]. I would now like to turn the presentation over to Sarah Crews, Director of Inv ...

Exhibit 99.2 GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FIRST QUARTER 2024 Table of Contents Page Investor Letter 3 Use of Non-GAAP Measures 4 Results of Operations and Selected Operating Performance Measures 5 Financial Highlights 6 Consolidated Quarterly Results Consolidated Net Income (Loss) by Quarter 8 Reconciliation of Net Income (Loss) to Adjusted Operating Income (Loss) 9 Consolidated Balance Sheets 10-11 Consolidated Balance Sheets by Segment 12-13 Quarterly Results by Business Adjusted Operatin ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32195 GENWORTH FINANCIAL, INC. (Exact name of registrant as specified in its charter) Delaware 80-0873306 (State or other jurisdiction of (I.R.S ...

Genworth Financial, Inc. (NYSE:GNW) Q4 2023 Earnings Conference Call February 22, 2024 9:00 AM ET Corporate Participants Brian Johnson - Senior Vice President, Financial Planning and Analysis Jerome Upton - Executive Vice President and Chief Financial Officer Tom McInerney - President and Chief Executive Officer Jamala Arland - Executive Vice President, U.S. Life Insurance Conference Call Participants Ryan Krueger - KBW Arthur Tetyevsky - Cantor Fitzgerald Operator Good morning, ladies and gentlemen. Welcom ...

Fourth Quarter 2023 Earnings Summary February 21, 2024 ...